BioStem Technologies (BSEM) Expected to Announce Quarterly Earnings on Monday

BioStem Technologies (OTCMKTS:BSEM) is projected to post its quarterly earnings results after the market closes on Monday, April 7th. Analysts expect the company to announce earnings of $0.37 per share and revenue of $86.69 million for the quarter.

BioStem Technologies Stock Down 1.9 %

BioStem Technologies stock opened at $8.29 on Friday. The firm has a 50 day moving average price of $12.76 and a 200-day moving average price of $13.78. BioStem Technologies has a twelve month low of $6.77 and a twelve month high of $28.26. The company has a market capitalization of $138.48 million, a P/E ratio of 12.19 and a beta of -0.39.

About BioStem Technologies

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.